Ultrasound-guided lymph node biopsies: feasible and safe use of pathology services in a resource-limited, high TB/HIV prevalence setting

This is a preview and has not been published.

Ultrasound-guided lymph node biopsies: feasible and safe use of pathology services in a resource-limited, high TB/HIV prevalence setting

Authors

  • Tapiwa Kumwenda Lighthouse Clinic Trust, Lilongwe, Malawi
  • Veronica Phiri Lighthouse Clinic Trust, Lilongwe, Malawi
  • Kelvin Rambik Lighthouse Clinic Trust, Lilongwe, Malawi
  • Bianca Sossen Department of Medicine, University of Cape Town Faculty of Health Sciences, Cape Town, South Africa
  • Tamiwe Tomoka Pathology Lab, University of North Carolina School of Medicine, Lilongwe, Malawi
  • George Fedoriw Department of Pathology and Lab Medicine, University of North Carolina School of Medicine, Chapel Hill, USA, Institute for Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill,USA and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
  • Mathews S. Painschab UNC Project Malawi, Lilongwe, Malawi and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA
  • Ethel Rambik Lighthouse Clinic Trust, Lilongwe, Malawi
  • Claudia Wallrauch Lighthouse Clinic Trust, Lilongwe, Malawi and Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital Munich, LMU Munich, Munich, Germany
  • Tom Heller Lighthouse Clinic Trust, Lilongwe, Malawi and International Training and Education Center for Health, University of Washington, Seattle, Washington, USA

Keywords:

HIV, lymphadenopathy, ultrasound-guided biopsy, low-resource setting, pathology

Abstract

Background: Enlarged lymph nodes (LN) pose diagnostic challenges for people with HIV (PWH). While tuberculosis (TB) is a common cause in low-income settings, lymphomas and Kaposi’s sarcoma must also be considered. Ultrasound and symptoms cannot distinguish between these conditions, and histology is often needed, but limited resources in low-income countries restrict sampling. To minimize the need for excisional biopsies, we introduced an algorithm for ultrasound-guided core-needle biopsies (CNB) after negative fine-needle aspiration (FNA) results from Xpert-Ultra.
Methods: At the Lighthouse clinic in Lilongwe, Malawi, patients with peripheral lymphadenopathy underwent ultrasound-guided FNA. Negative Xpert-Ultra results prompted CNB using Tru-Cut needles, with samples sent for pathology. We retrospectively analyzed 12 months of data, including histology results and abdominal ultrasound findings.
Results: In 2024, 53 CNBs were performed, 96% in HIV patients. No significant complications were observed. A conclusive diagnosis was reached in 77% of cases, with the most common diagnoses being hematological malignancies (54%), reactive LN (15%), Kaposi’s sarcoma (12%), and metastatic carcinoma (10%). Infections, including granulomatous inflammation, were found in 10% of cases. Hypoechoic spleen lesions were more frequent in patients with hematological diseases (p=0.03).
Conclusion: Ultrasound-guided CNB of enlarged peripheral LN is a safe, effective addition to routine care in ART clinics. After negative Xpert-Ultra FNA, hematological malignancies were common. Abdominal ultrasound findings were frequently abnormal, particularly hypoechoic spleen lesions in hematological diseases.

 

References

1 Barr DA, Lewis JM, Feasey N, et al. Mycobacterium tuberculosis bloodstream infection

prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review

and meta-analysis of individual patient data. Lancet Infect Dis 2020; 20: 742–52.

2 Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem

studies of HIV-infected adults and children in resource-limited settings: systematic

review and meta-analysis. AIDS 2015; 29: 1987–2002.

3 WHO. Global tuberculosis report 2024.

4 World Health Organization. WHO Tuberculosis profile: African region.

https://worldhealthorg.shinyapps.io/tb_profiles/?_inputs_&tab=%22tables%22&lan=%22E

N%22&entity_type=%22group%22&group_code=%22AFR%22 (accessed June 24, 2025).

5 Mekonnen D, Derbie A, Abeje A, et al. Epidemiology of tuberculous lymphadenitis in

Africa: A systematic review and meta-analysis. PLOS ONE 2019; 14: e0215647.

6 Reddy DL, Venter WDF, Pather S. Patterns of Lymph Node Pathology; Fine Needle

Aspiration Biopsy as an Evaluation Tool for Lymphadenopathy: A Retrospective Descriptive

Study Conducted at the Largest Hospital in Africa. PLOS ONE 2015; 10: e0130148.

7 Antel K, Oosthuizen J, Brown K, et al. Focused investigations to expedite cancer diagnosis

among patients with lymphadenopathy in a tuberculosis and HIV-endemic region. AIDS

2023; 37: 587–94.

8 Rambiki E, Rambiki K, Khalani J, et al. Letters to the Editor Low Rates of Side Effects in

Paclitaxel Chemotherapy for Kaposi Sarcoma and Feasibility of Treatment in Outpatient

ART Clinic Settings in Malawi. J Acquir Immune Defic Syndr 2024; 96: e1–2.

9 Chinula L, Moses A, Gopal S. HIV-associated malignancies in sub-Saharan Africa: progress,

challenges, and opportunities. Curr Opin HIV AIDS 2017; 12: 89–95.

10 Chalya PL, Mbunda F, Rambau PF, et al. Kaposi’s sarcoma: a 10-year experience with

248 patients at a single tertiary care hospital in Tanzania. BMC Res Notes 2015; 8: 440.

11 Wallrauch C. Lymphadenopathy due to Kikuchi-Fujimoto disease – A rare differential

for a common presentation. Malawi Med J 2018; 30: 302.

12 Montgomery ND, Tomoka T, Krysiak R, et al. Practical Successes in Telepathology

Experiences in Africa. Clin Lab Med 2018; 38: 141–50.

13 Ahuja AT, Ying M. Sonographic Evaluation of Cervical Lymph Nodes. Am J Roentgenol

2005; 184: 1691–9.

14 Khanna R, Sharma AD, Khanna S, Kumar M, Shukla RC. Usefulness of ultrasonography

for the evaluation of cervical lymphadenopathy. World J Surg Oncol 2011; 9: 29.

15 Dhana A, Hamada Y, Kengne AP, et al. Tuberculosis screening among HIV-positive

inpatients: a systematic review and individual participant data meta-analysis. Lancet HIV

2022; 9: e233.

16 Dhana A, Hamada Y, Kengne AP, et al. Tuberculosis screening among ambulatory

people living with HIV: a systematic review and individual participant data meta-analysis.

Lancet Infect Dis 2022; 22: 507–18.

17 World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3:

diagnosis. 2025.

18 Kohli M, Schiller I, Dendukuri N, et al. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays 380

for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database

Syst Rev 2021; 2021. DOI:10.1002/14651858.CD012768.pub3.

19 Heller T, Wallrauch C, Goblirsch S, Brunetti E. Focused assessment with sonography

for HIV-associated tuberculosis (FASH): a short protocol and a pictorial review. Crit

Ultrasound J 2012; 4: 21.

20 Lighthouse Group, Phiri S, Neuhann F, et al. The path from a volunteer initiative to

an established institution: evaluating 15 years of the development and contribution of the

Lighthouse trust to the Malawian HIV response. BMC Health Serv Res 2017; 17: 54.

21 Gopal S, Krysiak R, Liomba NG, et al. Early Experience after Developing a Pathology

Laboratory in Malawi, with Emphasis on Cancer Diagnoses. PLoS ONE 2013; 8: e70361.

22 Montgomery ND, Liomba NG, Kampani C, et al. Accurate Real-Time Diagnosis of

Lymphoproliferative Disorders in Malawi Through Clinicopathologic Teleconferences: A

Model for Pathology Services in Sub-Saharan Africa. Am J Clin Pathol 2016; 146: 423–30.

23 Brownlee AJ, Dewey M, Chagomerana MB, et al. Update on pathology laboratory

development and research in advancing regional cancer care in Malawi. Front Med 2024;

11. DOI:10.3389/fmed.2024.1336861.

24 Antel K, Oosthuizen J, Malherbe F, et al. Diagnostic accuracy of the Xpert MTB/Rif

Ultra for tuberculosis adenitis. BMC Infect Dis 2020; 20: 33.

25 Kong L, Xie B, Liu Q, et al. Application of acid-fast staining combined with GeneXpert

MTB/RIF in the diagnosis of non-tuberculous mycobacteria pulmonary disease. Int J Infect

Dis 2021; 104: 711–7.

26 Belard S, Taccari F, Kumwenda T, Huson MA, Wallrauch C, Heller T. Point-of-care

ultrasound for tuberculosis and HIV—revisiting the focused assessment with sonography

for HIV-associated tuberculosis (FASH) protocol and its differential diagnoses. Clin

Microbiol Infect 2024; 30: 320–7.

27 Bhatia K, Sahdev A, Reznek RH. Lymphoma of the Spleen. Semin Ultrasound CT MRI

2007; 28: 12–20.

28 Adams EC, Antel K, Bailey JL, et al. Diagnostic use of abdominal ultrasound in

detecting extrapulmonary tuberculosis or lymphoma in an HIV-endemic region. South Afr J

HIV Med 2025; 26. DOI:10.4102/sajhivmed.v26i1.1679.

29 Freitag B, Sultanli A, Grilli M, et al. Clinically Diagnosed Tuberculosis and Mortality in

High Burden Settings: A Systematic Review and Meta-Analysis. eClinicalMedicine 2025.

DOI:10.2139/ssrn.5091666.

30 Huson MAM, Kumwenda T, Gumulira J, Rambiki E, Wallrauch C, Heller T. Ultrasound

findings in Kaposi sarcoma patients: overlapping sonographic features with disseminated

tuberculosis. Ultrasound J 2023; 15: 27.

How to Cite

1.
Kumwenda T, Phiri V, Rambik K, et al. Ultrasound-guided lymph node biopsies: feasible and safe use of pathology services in a resource-limited, high TB/HIV prevalence setting. Ultrasound J. 18(1):18321. doi:10.5826/tuj.2026.18321